Indian Journal of Urology Users online:2939  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
REVIEW ARTICLE
Year : 2015  |  Volume : 31  |  Issue : 2  |  Page : 102-105

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?


1 Division of Urology and Kidney Transplantation, American University of Beirut, Beirut, Lebanon
2 Division of Oncology, American University of Beirut, Beirut, Lebanon

Correspondence Address:
Dr. Yaser El-Hout
P.O. Box 11-0236, Riad El Solh, Beirut 1107 2020, Beirut
Lebanon
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-1591.154300

Rights and Permissions

Nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) offers comparable oncologic results, but a lower risk of chronic kidney disease, when compared with radical nephrectomy. However, there are limited data in the literature examining the safety of NSS in the setting of metastatic RCC. To evaluate the feasibility of NSS and impact on cancer-specific survival (CSS) in patients with metastatic disease, we performed a systematic review of the literature. There is ample evidence that NSS is feasible in metastatic RCC, with comparable results in terms of CSS compared with radical cytoreductive nephrectomy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3480    
    Printed57    
    Emailed1    
    PDF Downloaded184    
    Comments [Add]    

Recommend this journal

 

HEALTHWARE INDIA